Dyne Therapeutics, Inc. (DYN)
DYN Stock Price Chart
Explore Dyne Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze DYN price movements and trends.
DYN Company Profile
Discover essential business fundamentals and corporate details for Dyne Therapeutics, Inc. (DYN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
17 Sept 2020
Employees
192.00
Website
https://www.dyne-tx.comCEO
John G. Cox
Description
Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral dystrophy, in addition to other rare skeletal, cardiac, and metabolic muscle diseases. The company was founded in 2017 and maintains its corporate headquarters in Waltham, Massachusetts.
DYN Financial Timeline
Browse a chronological timeline of Dyne Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Jul 2026
EPS estimate is -$0.74.
Earnings released on 11 May 2026
EPS came in at -$0.73 surpassing the estimated -$0.77 by +5.48%.
Earnings released on 2 Mar 2026
EPS came in at -$0.76 falling short of the estimated -$0.74 by -2.70%.
Earnings released on 5 Nov 2025
EPS came in at -$0.76 surpassing the estimated -$0.81 by +6.17%.
Earnings released on 28 Jul 2025
EPS came in at -$0.97 surpassing the estimated -$0.99 by +2.02%.
Earnings released on 8 May 2025
EPS came in at -$1.05 falling short of the estimated -$0.88 by -19.32%.
Earnings released on 27 Feb 2025
EPS came in at -$0.88 surpassing the estimated -$0.92 by +4.35%.
Earnings released on 12 Nov 2024
EPS came in at -$0.96 falling short of the estimated -$0.71 by -35.21%.
Earnings released on 12 Aug 2024
EPS came in at -$0.70 surpassing the estimated -$0.72 by +2.78%.
Earnings released on 2 May 2024
EPS came in at -$0.81 matching the estimated -$0.81.
Earnings released on 5 Mar 2024
EPS came in at -$1.09 falling short of the estimated -$0.92 by -18.48%, while revenue for the quarter reached $3.79m .
Earnings released on 30 Oct 2023
EPS came in at -$0.99 falling short of the estimated -$0.86 by -15.12%.
Earnings released on 3 Aug 2023
EPS came in at -$1.08 falling short of the estimated -$0.81 by -33.33%.
Earnings released on 11 May 2023
EPS came in at -$0.78 falling short of the estimated -$0.77 by -1.30%.
Earnings released on 2 Mar 2023
EPS came in at -$0.74 surpassing the estimated -$0.84 by +11.90%.
Earnings released on 3 Nov 2022
EPS came in at -$0.80 surpassing the estimated -$0.95 by +15.79%.
Earnings released on 4 Aug 2022
EPS came in at -$1.01 falling short of the estimated -$0.79 by -27.85%.
Earnings released on 2 May 2022
EPS came in at -$0.69 surpassing the estimated -$0.88 by +21.59%.
Earnings released on 10 Mar 2022
EPS came in at -$1.00 falling short of the estimated -$0.99 by -1.01%.
Earnings released on 4 Nov 2021
EPS came in at -$0.83 falling short of the estimated -$0.65 by -27.69%.
Earnings released on 5 Aug 2021
EPS came in at -$0.58 falling short of the estimated -$0.55 by -5.45%.
DYN Stock Performance
Access detailed DYN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
